Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
Actinium Pharmaceuticals, Inc. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $2,109,005 between 2020 and 2023. These are non-dilutive federal research grants, not equity financing. The company is based in New York, New York.
No investors recorded yet for Actinium Pharmaceuticals, Inc..
Add an investorActinium Pharmaceuticals, Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Actinium Pharmaceuticals, Inc..
Add diversity data